Home LiteratureArticle Details
PMID: 7790462 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't

Production of elastase, exotoxin A, and alkaline protease in sputa during pulmonary exacerbation of cystic fibrosis in patients chronically infected by Pseudomonas aeruginosa.

Journal of clinical microbiology ·Vol. 33 ·No. 4 ·1995-04-00 ·Pages 924-9

Jaffar-Bandjee MC, Lazdunski A, Bally M, Carrère J, Chazalette JP, Galabert C

Abstract

Secretion of Pseudomonas aeruginosa elastase, exotoxin A, and alkaline protease in sputum during bronchopulmonary exacerbations was examined in 18 cystic fibrosis patients chronically infected with this microorganism. The patients were studied during one or several exacerbation periods necessitating hospitalizations of 12 to 20 days. In all cases, P. aeruginosa was present in bronchial secretions at admission and was not eradicated after treatment. The P. aeruginosa density decreased significantly after antibiotic therapy but remained greater than 10(6) CFU/g of sputum in most cases. Significant amounts of P. aeruginosa exoproteins were measured in total homogenized bronchial secretions by immunoenzymatic assays. The detection of higher levels of exoproteins at admission, the significant decrease after treatment, and the absence of exoproteins during intercrisis phases constituted arguments for a renewal of virulence of P. aeruginosa during exacerbations. Nevertheless, the concomitant changes in bacteria load and the triggering of the inflammatory process and immune complex formation could also contribute to pulmonary exacerbations.

MeSH Terms
ADP Ribose Transferases Adolescent Adult Anti-Bacterial Agents/therapeutic use Bacterial Toxins Child Cystic Fibrosis/complications,microbiology Endopeptidases/biosynthesis Exotoxins/biosynthesis Female Humans Kinetics Male Pancreatic Elastase/biosynthesis Pneumonia/complications,metabolism,microbiology Pseudomonas Infections/complications,metabolism,microbiology Pseudomonas aeruginosa/metabolism,pathogenicity Sputum/metabolism,microbiology Virulence Factors
Chemicals
Anti-Bacterial Agents Bacterial Toxins Exotoxins Virulence Factors ADP Ribose Transferases toxA protein, Pseudomonas aeruginosa Endopeptidases Pancreatic Elastase
Authors & Affiliations
6 authors, click to expand affiliations / ORCID
Jaffar-Bandjee M C
CERM, Hôpital Renée Sabran, Giens, Hyères, France.
Lazdunski A
Bally M
Carrère J
Chazalette J P
Galabert C
References (35)
35 references, click to expand
  1. Epidemiological investigations of the respiratory tract bacteriology in patients with cystic fibrosis.
    Acta Pathol Microbiol Scand B Microbiol Immunol. 1974 Aug;82(4):541-50 PMID: 4153350
  2. The impact of respiratory viral infections in patients with cystic fibrosis.
    Clin Rev Allergy. 1991 Spring-Summer;9(1-2):87-102 PMID: 1884330
  3. Mucosal immunity to Pseudomonas aeruginosa alginate in cystic fibrosis.
    APMIS. 1992 Apr;100(4):326-34 PMID: 1581041
  4. Molecular epidemiology of chronic pulmonary colonisation by Pseudomonas aeruginosa in cystic fibrosis.
    J Med Microbiol. 1993 Jan;38(1):29-33 PMID: 8418289
  5. Co-existence of colonies with different serotypes and other biological characteristics in clinical isolates of Pseudomonas aeruginosa.
    Microbiol Immunol. 1992;36(11):1113-8 PMID: 1491616
  6. Elevated exoenzyme expression by Pseudomonas aeruginosa is correlated with exacerbations of lung disease in cystic fibrosis.
    Pediatr Pulmonol. 1993 Mar;15(3):135-9 PMID: 8327274
  7. Direct double antibody sandwich immunoassay for Pseudomonas aeruginosa elastase.
    J Immunol Methods. 1993 Aug 26;164(1):27-32 PMID: 8360507
  8. Immunoenzymometric assays for alkaline protease and exotoxin A from Pseudomonas aeruginosa: development and use in detecting exoproteins in clinical isolates from patients with cystic fibrosis.
    Eur J Clin Chem Clin Biochem. 1994 Dec;32(12):893-9 PMID: 7696436
  9. Antibodies to proteases and exotoxin A of Pseudomonas aeruginosa in patients with cystic fibrosis: Demonstration by radioimmunoassay.
    J Infect Dis. 1978 Jul;138(1):49-8 PMID: 98596
  10. Is anti-Pseudomonas therapy warranted in acute respiratory exacerbations in children with cystic fibrosis?
    J Pediatr. 1980 Jul;97(1):144-7 PMID: 7381634
  11. Production of mucoid microcolonies by Pseudomonas aeruginosa within infected lungs in cystic fibrosis.
    Infect Immun. 1980 May;28(2):546-56 PMID: 6772562
  12. Bacteriology of sputum in cystic fibrosis: evaluation of dithiothreitol as a mucolytic agent.
    J Clin Microbiol. 1980 Jun;11(6):552-7 PMID: 6776135
  13. Ultrasonic method of sputum homogenization and its application in the study of the enzymic content of sputum.
    Clin Chim Acta. 1981 Jun 2;113(1):105-9 PMID: 6263524
  14. A double-blind controlled trial of anti-Pseudomonas chemotherapy of acute respiratory exacerbations in patients with cystic fibrosis.
    J Pediatr. 1981 Aug;99(2):307-14 PMID: 7019407
  15. Respiratory infections in cystic fibrosis patients caused by virus, chlamydia and mycoplasma--possible synergism with Pseudomonas aeruginosa.
    Acta Paediatr Scand. 1981 Sep;70(5):623-8 PMID: 6798822
  16. Contribution of toxin A and elastase to virulence of Pseudomonas aeruginosa in chronic lung infections of rats.
    Infect Immun. 1982 Jun;36(3):1223-8 PMID: 6807846
  17. Inactivation of human bronchial mucosal proteinase inhibitor by Pseudomonas aeruginosa elastase.
    Am Rev Respir Dis. 1982 Dec;126(6):1070-3 PMID: 6817677
  18. Clinical and bacteriological responses to three antibiotic regimens for acute exacerbations of cystic fibrosis: ticarcillin-tobramycin, azlocillin-tobramycin, and azlocillin-placebo.
    J Infect Dis. 1983 Mar;147(3):559-67 PMID: 6339649
  19. Proteases of Pseudomonas aeruginosa in patients with cystic fibrosis.
    J Infect Dis. 1983 Apr;147(4):744-50 PMID: 6404993
  20. Longitudinal study of immune response to Pseudomonas aeruginosa antigens in cystic fibrosis.
    Infect Immun. 1983 Oct;42(1):197-201 PMID: 6413411
  21. Purification of human plasma alpha 1-proteinase inhibitor and its inactivation by Pseudomonas aeruginosa elastase.
    J Biochem. 1984 Mar;95(3):795-804 PMID: 6427201
  22. Granulocyte neutral proteases and Pseudomonas elastase as possible causes of airway damage in patients with cystic fibrosis.
    J Infect Dis. 1984 Apr;149(4):523-31 PMID: 6427360
  23. Detection of proteases of Pseudomonas aeruginosa in immune complexes isolated from sputum of cystic fibrosis patients.
    Acta Pathol Microbiol Immunol Scand C. 1984 Oct;92(5):307-12 PMID: 6440414
  24. The contribution of exoproducts to virulence of Pseudomonas aeruginosa.
    Can J Microbiol. 1985 Apr;31(4):387-92 PMID: 2988728
  25. Association of systemic immune complexes, complement activation, and antibodies to Pseudomonas aeruginosa lipopolysaccharide and exotoxin A with mortality in cystic fibrosis.
    Am Rev Respir Dis. 1986 Apr;133(4):648-52 PMID: 3083745
  26. Elastase from polymorphonuclear leucocytes: a regulatory enzyme in immune complex disease.
    Clin Exp Immunol. 1986 Jun;64(3):597-605 PMID: 2947759
  27. Ceftazidime monotherapy vs. combined therapy in Pseudomonas pulmonary infections in cystic fibrosis.
    Pediatr Infect Dis J. 1987 Jul;6(7):648-53 PMID: 3302917
  28. Sputum changes associated with therapy for endobronchial exacerbation in cystic fibrosis.
    J Pediatr. 1988 Apr;112(4):547-54 PMID: 3127569
  29. Reduction of sputum Pseudomonas aeruginosa density by antibiotics improves lung function in cystic fibrosis more than do bronchodilators and chest physiotherapy alone.
    Am Rev Respir Dis. 1990 Apr;141(4 Pt 1):914-21 PMID: 2109558
  30. Cystic fibrosis. 1. Pseudomonas aeruginosa infection in cystic fibrosis and its management.
    Thorax. 1990 Nov;45(11):881-4 PMID: 2256020
  31. Effects of human neutrophil elastase and Pseudomonas aeruginosa proteinases on human respiratory epithelium.
    Am J Respir Cell Mol Biol. 1991 Jan;4(1):26-32 PMID: 1898852
  32. Proteolytic inactivation of alpha 1-proteinase inhibitor in infected bronchial secretions from patients with cystic fibrosis.
    Eur Respir J. 1991 Jan;4(1):40-9 PMID: 2026237
  33. Respiratory tract colonization with Pseudomonas aeruginosa in cystic fibrosis: correlations between anti-Pseudomonas aeruginosa antibody levels and pulmonary function.
    Pediatr Pulmonol. 1991;10(2):92-100 PMID: 1903199
  34. Inflammation in the lung in cystic fibrosis. A vicious cycle that does more harm than good?
    Clin Rev Allergy. 1991 Spring-Summer;9(1-2):119-42 PMID: 1884321
  35. Pseudomonas aeruginosa infection in cystic fibrosis. Diagnostic and prognostic significance of Pseudomonas aeruginosa precipitins determined by means of crossed immunoelectrophoresis.
    Scand J Respir Dis. 1977 Apr;58(2):65-79 PMID: 404701
Article Info
Journal
Journal of clinical microbiology
Abbr.
J Clin Microbiol
ISSN
0095-1137
Published
1995-04-00
Pages
924-9
Language
English
Region
United States
NLM ID
7505564
PMCID
PMC228069
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]